John A Chabot, MD

Dr. Quezada is an Assistant Professor of Clinical Medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine. A native of Washington Heights, he received his Sc.B. with Honors in Biology from Brown University in Providence, Rhode Island, and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency training in Internal Medicine, and Fellowship in Pulmonary and Critical Care Medicine, at Columbia University Medical Center, serving as Chief Fellow on his last year of fellowship training. He is board-certified in Internal Medicine and Pulmonary Disease by the American Board of Internal Medicine. Dr. Quezada specializes in providing excellent care of patients suffering from lung disease, including patients with asthma, COPD, and interstitial lung disease. He also has special interest in smoking cessation and interventional bronchoscopy. His research interests include smoking cessation, COPD and asthma, serving as a co-primary investigator in a multicenter NIH-sponsored clinical trial. He has also performed research looking into the relationship between sensitization and exposure to indoor allergens in asthma patients residing in inner city neighborhoods, and the development of tools to help identify patients with early COPD.

Marco B. Zoccali is a minimally invasive surgeon with extensive expertise in the treatment of the broad range of colorectal diseases including IBD, colon and rectal cancers, and benign colorectal diseases. He received his medical degree at the Catholic University in Rome, Italy where he also completed his surgical training. He then came to the USA where he did a Minimally Invasive Gastrointestinal Surgery Fellowship at the University of Chicago followed by a surgical residency at Weill Cornell Medical Center. He then completed his Colon and Rectal Surgery Fellowship at the University of Chicago. Although committed to managing the entire spectrum of pathologies that can affect the lower intestinal tract, his personal interest lies mostly in minimally invasive approaches to colorectal conditions – including the robotic platform – and the management of inflammatory bowel diseases. Beyond his clinical practice, Dr. Zoccali is also a prolific researcher. He has published more than 50 articles in major surgical journals including The Journal of The American College of Surgeons, The British Journal of Surgery and Inflammatory Bowel Disease, and has contributed to several book chapters.

Dr. Wiechmann is a board certified surgeon specializing in breast cancer, who was recognized with honors by the Breast Cancer Alliance, the Susan G. Komen for the Cure foundation and the Society of Surgical Oncology. Dr. Wiechmann's dedication to patient-driven, personalized care has earned many awards. These include the “Faces of Respect” Award at Montefiore Medical Center (2011-2013) and the Greenwich Hospital Quality Award (2015). Her peers recently selected Dr Wiechmann as a Castle Connolly Top Doctor, a nationally ranked service whose mission is to help consumers find the best healthcare; she has been listed in the “Guide to America’s Top Surgeons” for the past 3 years. Dr. Wiechmann is a breast surgeon with over 10 years of experience at the Comprehensive Breast Center of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia, a multi-site, multi-disciplinary entity that incorporates the legacy of innovation and trust associated with the Columbia University Irving Medical Center. She works closely with a multi-disciplinary team including radiologists, medical oncologists, radiation oncologists, plastic surgeons and other breast cancer support staff. Her goal is to make patient and family experience as simple, thorough, and streamlined as possible. Dr Wiechmann approaches each patient in a personal, kind, and compassionate way and believes in shared decision-making and teamwork. She speaks English, Spanish, and Italian fluently and can conduct the consultation in any of those languages. In the clinic, Dr. Wiechmann's interests include triple negative breast cancer (ER, PR, and HER2 negative), the genetic and familial predisposition to breast cancer, and disparities in cancer treatment and outcomes. Dr Wiechmann, who was born and raised in Florence, Italy, received her medical degree Magna Cum Laude at Universita' Degli Studi Di Firenze Facolta' Di Medicina e Chirurgia in Florence, Italy. She completed a General Surgery Residency at TUFTS, St. Elizabeth's Medical Center in Boston followed by a research fellowship in the prestigious laboratory of Dr Kent Osborne and Dr Rachel Schiff, at the Lester and Sue Smith Breast Center of the Dan L. Duncan Cancer Center at Baylor College of Medicine, in Houston, Texas. At Baylor, her research focused on the preclinical development of therapies targeting the HER2 receptor; her work was recognized by Komen/AACR. Dr Wiechmann’s work has been published in many surgical and the Breast Cancer Alliance, the Susan G. Komen for the Cure foundation and the Society of Surgical Oncology have repeatedly recognized oncology publications and her with awards for her research and scholarship. After completing her research at Baylor, Dr Wiechmann was the recipient of the Breast Cancer Alliance award that funded her clinical fellowship at Memorial Sloan-Kettering Cancer Center, which led to her participation in the prestigious ASCO/AACR (American Society for Clinical Oncology/American Association for Cancer Research) course, Methods in Clinical Cancer Research.